Provided by Tiger Trade Technology Pte. Ltd.

BAIYUNSHAN PH

15.710
-0.190-1.19%
Volume:216.00K
Turnover:3.40M
Market Cap:25.54B
PE:7.40
High:15.990
Open:15.990
Low:15.680
Close:15.900
52wk High:19.716
52wk Low:14.000
Shares:1.63B
HK Float Shares:219.90M
Volume Ratio:0.45
T/O Rate:0.10%
Dividend:0.96
Dividend Rate:6.08%
EPS(LYR):2.124
ROE:7.43%
ROA:2.37%
PB:0.56
PE(LYR):7.40
PS:0.28

Loading ...

GPC and Baiyunshan Launch Phase One of Financial Transformation Initiative

Deep News
·
Mar 17

Baiyunshan Pharma's Subsidiary Gets Nod for Xu Han Ting Granules' Trial As Respiratory Treatment

MT Newswires Live
·
Mar 17

Hong Kong Market Announcements: Ant Group's Acquisition of Bright Smart Receives Approval, Trading Resumes March 17

Stock News
·
Mar 17

Clinical Trial Application for Baiyunshan's Xuhanting Granules in Pediatric Recurrent Respiratory Infections Receives Approval

Stock News
·
Mar 16

Baiyunshan Receives SSE Approval for Guangzhou Pharmaceutical Receivables ABS Listing

Stock News
·
Mar 16

Baiyunshan Pharmaceutical (00874) Sets 20 Mar 2026 Board Meeting to Approve FY2025 Audited Results

Bulletin Express
·
Mar 10

JPMorgan Reduces Stake in BAIYUNSHAN PH, Selling 207,200 Shares at HK$18.75 Each

Deep News
·
Mar 09

JPMorgan Reduces Stake in Baiyunshan by 207,200 Shares at HK$18.75 Per Share

Stock News
·
Mar 06

BAIYUNSHAN PH (00874) Announces Board Composition and Committee Structure

Bulletin Express
·
Mar 06

BAIYUNSHAN PH (00874) Appoints Huang Xuezhen as New Authorized Representative

Stock News
·
Mar 06

Guangzhou Baiyunshan Pharmaceutical - Cheng Ning Resigning From Her Positions as Vice Chairperson and an Executive Director

THOMSON REUTERS
·
Mar 06

Guangzhou Baiyunshan (00874.HK, 600332.SSE) Reports Unchanged Share Capital in February 2026

Bulletin Express
·
Mar 03

Baiyunshan Pharmaceutical's Subsidiaries Apply Drugs for Renewal in China's Centralized Procurement

MT Newswires Live
·
Feb 12

Baiyunshan Pharmaceutical Gets China Nod for Changes to Mouthwash Spray's Registration

MT Newswires Live
·
Feb 11

Baiyunshan's Penicillin Sodium Injection Achieves Generic Drug Equivalence

Stock News
·
Feb 11

Eight Government Bodies Issue Plan to Boost Traditional Chinese Medicine Industry Development

Stock News
·
Feb 06

JPMorgan Boosts Stake in Baiyunshan by 360,600 Shares at HK$18.85 Each

Stock News
·
Feb 04

Guangzhou Baiyunshan (00874) Publishes January 2026 Monthly Return on Movements in Securities

Bulletin Express
·
Feb 03

Baiyunshan Pharmaceutical's Unit Gets License to Produce Xuhanting Granules

MT Newswires Live
·
Feb 03

Baiyunshan (00874): Subsidiary's Pharmaceutical Production License Amended

Stock News
·
Feb 02